✦ LIBER ✦

The Effect of Neoadjuvant Intraluminal Brachytherapy and Chemotherapy After Conventional Neoadjuvant Chemoradiation on Pathologic Response in Patients With Locally Advanced Rectal Cancer: A Phase 2 Nonrandomized Clinical Trial

✍ Scribed by Lashkari, M.; Mir, A.; Aghili, M.; Farhan, F.; Kazemian, A.; Jaberi, R.; Babaei, M.

Book ID: 126978925
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 55 KB
Volume: 90
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.05.1231

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The added value of the combined evaluati

The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

✍ Therasse, P.; Mauriac, L.; Welnicka, M.; Bruning, P.; Cufer, T.; Lichinitser, R. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views